{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:03:57Z","timestamp":1787238237214,"version":"build-2736575974"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-024-02974-9","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T17:26:55Z","timestamp":1730482015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Technological Strategies Applied to Pharmaceutical Systems for Intranasal Administration of Drugs Intended for Neurological Treatments: A Review"],"prefix":"10.1208","volume":"25","author":[{"given":"Maria Vitoria Gouveia","family":"Botan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica Bassi","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4838-5742","authenticated-orcid":false,"given":"Marcos Luciano","family":"Bruschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"2974_CR1","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.2147\/IJN.S208332","volume":"14","author":"H Yavarpour-Bali","year":"2019","unstructured":"Yavarpour-Bali H, Pirzadeh M, Ghasemi-Kasman M. Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders. Int J Nanomed. 2019;14:4449\u201360.","journal-title":"Int J Nanomed"},{"key":"2974_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","volume":"19","author":"VL Feigin","year":"2020","unstructured":"Feigin VL, Vos T, Nichols E, Owolabi MO, Carroll WM, Dichgans M, et al. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol. 2020;19:255\u201365.","journal-title":"Lancet Neurol"},{"key":"2974_CR3","doi-asserted-by":"publisher","unstructured":"Huang Y, Li Y, Pan H, Han L. Global, regional, and national burden of neurological disorders in 204 countries and territories worldwide. J Glob Health. 2023;13. https:\/\/doi.org\/10.7189\/jogh.13.04160.","DOI":"10.7189\/jogh.13.04160"},{"key":"2974_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ejpb.2018.05.009","volume":"128","author":"V Bourganis","year":"2018","unstructured":"Bourganis V, Kammona O, Alexopoulos A, Kiparissides C. Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics. Eur J Pharm Biopharm. 2018;128:337\u201362.","journal-title":"Eur J Pharm Biopharm"},{"key":"2974_CR5","doi-asserted-by":"publisher","unstructured":"Ul Islam S, Shehzad A, Bilal Ahmed M, Lee YS. Intranasal delivery of nanoformulations: A potential way of treatment for neurological disorders. Molecules. 2020;25. https:\/\/doi.org\/10.7189\/jogh.13.04160.","DOI":"10.7189\/jogh.13.04160"},{"key":"2974_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics12080697","volume":"12","author":"B Sipos","year":"2020","unstructured":"Sipos B, Szab\u00f3-R\u00e9v\u00e9sz P, Cs\u00f3ka I, Pallagi E, Dob\u00f3 DG, B\u00e9lteky P, et al. Quality by design based formulation study of meloxicam-loaded polymeric micelles for intranasal administration. Pharmaceutics. 2020;12:1\u201329.","journal-title":"Pharmaceutics"},{"key":"2974_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1208\/s12248-015-9724-x","volume":"17","author":"MJR Ruigrok","year":"2015","unstructured":"Ruigrok MJR, de Lange ECM. Emerging insights for translational pharmacokinetic and pharmacokinetic-pharmacodynamic studies: towards prediction of nose-to-brain transport in humans. AAPS J. 2015;17:493\u2013505.","journal-title":"AAPS J"},{"key":"2974_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/cbdd.12268","volume":"83","author":"J Stockwell","year":"2014","unstructured":"Stockwell J, Abdi N, Lu X, Maheshwari O, Taghibiglou C. Novel central nervous system drug delivery systems. Chem Biol Drug Des. 2014;83:507\u201320.","journal-title":"Chem Biol Drug Des"},{"key":"2974_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-3-031-23112-4_8","volume-title":"Nasal Drug Delivery","author":"SK Amposah","year":"2023","unstructured":"Amposah SK, Amoafo EB. Delivery of vaccines via the Nasal Route. In: Pathak YV, Yadav HKS, editors. Nasal drug delivery. Springer International Publishing; 2023. pp. 127\u201339."},{"key":"2974_CR10","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1517\/17425247.2013.790887","volume":"10","author":"CV Pardeshi","year":"2013","unstructured":"Pardeshi CV, Belgamwar VS. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting. Expert Opin Drug Deliv. 2013;10:957\u201372.","journal-title":"Expert Opin Drug Deliv"},{"key":"2974_CR11","doi-asserted-by":"publisher","unstructured":"Mignani S, Shi X, Karpus A, Majoral JP. Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugs. Eur J Med Chem. 2021;209. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112905.","DOI":"10.1016\/j.ejmech.2020.112905"},{"key":"2974_CR12","doi-asserted-by":"publisher","unstructured":"Xu J, Tao J, Wang J. Design and Application in Delivery System of Intranasal Antidepressants. Front Bioeng Biotechnol. 2020;8. https:\/\/doi.org\/10.3389\/fbioe.2020.626882.","DOI":"10.3389\/fbioe.2020.626882"},{"key":"2974_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jconrel.2020.07.044","volume":"327","author":"M Agrawal","year":"2020","unstructured":"Agrawal M, Saraf S, Saraf S, Dubey SK, Puri A, Gupta U, et al. Stimuli-responsive in situ gelling system for nose-to-brain drug delivery. J Controlled Release. 2020;327:235\u201365.","journal-title":"J Controlled Release"},{"key":"2974_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jmbbm.2017.05.040","volume":"74","author":"SB De Souza Ferreira","year":"2017","unstructured":"De Souza Ferreira SB, Da Silva JB, Volpato Junqueira M, Belincanta Borghi-Pangoni F, Guttierres Gomes R, Luciano Bruschi M. The importance of the relationship between mechanical analyses and rheometry of mucoadhesive thermoresponsive polymeric materials for biomedical applications. J Mech Behav Biomed Mater. 2017;74:142\u201353.","journal-title":"J Mech Behav Biomed Mater"},{"key":"2974_CR15","doi-asserted-by":"publisher","unstructured":"da Silva JB, Cook MT, Bruschi ML. Thermoresponsive systems composed of poloxamer 407 and HPMC or NaCMC: mechanical, rheological and sol-gel transition analysis. Carbohydr Polym. 2020;240. https:\/\/doi.org\/10.1016\/j.carbpol.2020.116268.","DOI":"10.1016\/j.carbpol.2020.116268"},{"key":"2974_CR16","doi-asserted-by":"publisher","unstructured":"Yiannopoulou KG, Papageorgiou SG. Current and future treatments in Alzheimer Disease: an update. J Cent Nerv Syst Dis. 2020;12:117957352090739. https:\/\/doi.org\/10.1177\/1179573520907397.","DOI":"10.1177\/1179573520907397"},{"key":"2974_CR17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"S Tolosa","year":"2021","unstructured":"Tolosa S, Scholz W, Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol [Internet]. 2021;20:385\u201397.","journal-title":"Lancet Neurol [Internet]"},{"key":"2974_CR18","doi-asserted-by":"publisher","unstructured":"Nordengen K, Kirsebom BE, Henjum K, Selnes P, G\u00edslad\u00f3ttir B, Wettergreen M, et al. Glial activation and inflammation along the Alzheimer\u2019s disease continuum. J Neuroinflammation. 2019;16. https:\/\/doi.org\/10.1186\/s12974-019-1399-2.","DOI":"10.1186\/s12974-019-1399-2"},{"key":"2974_CR19","unstructured":"World Health Organization. Epilepsy [Internet]. 2022 [cited 2023 Sep 5]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/epilepsy"},{"key":"2974_CR20","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","volume":"15","author":"A Vezzani","year":"2019","unstructured":"Vezzani A, Balosso S, Ravizza T. Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy. Nat Rev Neurol. 2019;15:459\u201372.","journal-title":"Nat Rev Neurol"},{"key":"2974_CR21","doi-asserted-by":"publisher","unstructured":"Nogueira C, Lemos-Senna E, da Silva Vieira E, Sampaio TB, Mallmann MP, Oliveira MS, et al. \u03b2-caryophyllene cationic nanoemulsion for intranasal delivery and treatment of epilepsy: development and in vivo evaluation of anticonvulsant activity. J Nanopart Res. 2023;25. https:\/\/doi.org\/10.1007\/s11051-023-05668-8.","DOI":"10.1007\/s11051-023-05668-8"},{"key":"2974_CR22","unstructured":"U.S. Food and Drug Administration. FDA Grants Accelerated Approval for Alzheimer\u2019s Drug [Internet]. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-grants-accelerated-approval-alzheimers-drug. 2021 [cited 2024 Jul 22]."},{"key":"2974_CR23","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2147\/CIA.S325026","volume":"17","author":"M Vaz","year":"2022","unstructured":"Vaz M, Silva V, Monteiro C, Silvestre S. Role of Aducanumab in the treatment of Alzheimer\u2019s Disease: challenges and opportunities. Clin Interv Aging. 2022;17:797\u2013810.","journal-title":"Clin Interv Aging"},{"key":"2974_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.31887\/DCNS.2000.2.2\/lschneider","volume":"2","author":"S Schneider","year":"2000","unstructured":"Schneider S. A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer\u2019s disease. Dialogues Clin Neurosci. 2000;2:111\u201328.","journal-title":"Dialogues Clin Neurosci"},{"key":"2974_CR25","doi-asserted-by":"crossref","unstructured":"Beckers M, Bloem BR, Verbeek MM. Mechanisms of peripheral levodopa resistance in Parkinson\u2019s disease. NPJ Parkinsons Dis. 2022;8.","DOI":"10.1038\/s41531-022-00321-y"},{"key":"2974_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.31887\/DCNS.2004.6.3\/akorczyn","volume":"6","author":"AD Korczyn","year":"2004","unstructured":"Korczyn AD. Drug treatment of Parkinson\u2019s disease. Dialogues Clin Neurosci. 2004;6:315\u201322.","journal-title":"Dialogues Clin Neurosci"},{"key":"2974_CR27","unstructured":"U\u011fur Kaplan AB, \u00c7etin M. An Overview of Carbamazepine and Carbamazepine-Loaded Nanoparticle Drug Delivery Systems. ioneer and Contemporary Studies in Health Sciences. 2023."},{"key":"2974_CR28","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.2174\/1381612826666200331085854","volume":"26","author":"D Arora","year":"2020","unstructured":"Arora D, Bhatt S, Kumar M, Vattikonda HDC, Taneja Y, Jain V, et al. Intranasal lipid particulate drug Delivery systems: an update on Clinical challenges and Biodistribution studies of Cerebroactive drugs in Alzheimer\u2019s disease. Curr Pharm Des. 2020;26:3281\u201399.","journal-title":"Curr Pharm Des"},{"key":"2974_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","volume":"87","author":"L Illum","year":"2003","unstructured":"Illum L. Nasal drug delivery - possibilities, problems and solutions. J Controlled Release. 2003;87:187\u201398.","journal-title":"J Controlled Release"},{"key":"2974_CR30","doi-asserted-by":"publisher","unstructured":"Arora P, Sharma S, Garg S. Permeability issues in nasal drug delivery. Res Focus. 2002;7. https:\/\/doi.org\/10.1016\/s1359-6446(02)02452-2.","DOI":"10.1016\/s1359-6446(02)02452-2"},{"key":"2974_CR31","doi-asserted-by":"publisher","unstructured":"Desai GN, Dandagi PM, Kazi TM. Nanosized Intranasal Delivery of Novel Self-Assembled Cubic Liquid Crystals: Formulation and Evaluation. J Pharm Innov. 2022.\u00a0https:\/\/doi.org\/10.1016\/j.ajps.2017.09.001","DOI":"10.1016\/j.ajps.2017.09.001"},{"key":"2974_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/978-3-031-23112-4_13","volume-title":"Nasal Drug Delivery","author":"E Kahraman","year":"2023","unstructured":"Kahraman E, G\u00fcng\u00f6r S, \u00d6zsoy Y. Nasal delivery of high Molecular Weight drugs: recent trends and clinical evidence. In: Pathak YV, Yadav HKS, editors. Nasal drug delivery. 1st ed. Springer International Publishing; 2023. pp. 253\u201377.","edition":"1"},{"key":"2974_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1517\/17425247.2012.636801","volume":"9","author":"S Bahadur","year":"2012","unstructured":"Bahadur S, Pathak K. Physicochemical and physiological considerations for efficient nose-to-brain targeting. Expert Opin Drug Deliv. 2012;9:19\u201331.","journal-title":"Expert Opin Drug Deliv"},{"key":"2974_CR34","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.tiv.2011.10.011","volume":"26","author":"A Vetter","year":"2012","unstructured":"Vetter A, Augustijns P, Bernkop-Schn\u00fcrch A. Solubilizing agents in nasal formulations and their effect on ciliary beat frequency. Toxicol in Vitro. 2012;26:150\u20136.","journal-title":"Toxicol in Vitro"},{"key":"2974_CR35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4322\/polimeros.2014.043","volume":"24","author":"FC Carvalho","year":"2014","unstructured":"Carvalho FC, Chorilli M, Gremi\u00e3o MPD. Plataformas Bio(muco) adesivas polim\u00e9ricas baseadas em nanotecnologia para libera\u00e7\u00e3o controlada de f\u00e1rmacos - propriedades, metodologias e aplica\u00e7\u00f5es. Pol\u00edmeros. 2014;24:203\u201313.","journal-title":"Pol\u00edmeros"},{"key":"2974_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40263-020-00699-4","volume":"34","author":"T Doherty","year":"2020","unstructured":"Doherty T, Wajs E, Melkote R, Miller J, Singh JB, Weber MA. Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: results from the Clinical Development Program. CNS Drugs. 2020;34:299\u2013310.","journal-title":"CNS Drugs"},{"key":"2974_CR37","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s40268-021-00360-5","volume":"21","author":"AL Rabinowicz","year":"2021","unstructured":"Rabinowicz AL, Carrazana E, Maggio ET. Improvement of Intranasal Drug Delivery with Intravail\u00ae Alkylsaccharide Excipient as a mucosal absorption enhancer aiding in the treatment of conditions of the Central Nervous System. Drugs R D. 2021;21:361\u20139.","journal-title":"Drugs R D"},{"key":"2974_CR38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","volume":"143","author":"F Erd\u0151","year":"2018","unstructured":"Erd\u0151 F, Bors LA, Farkas D, Bajza \u00c1, Gizurarson S. Evaluation of intranasal delivery route of drug administration for brain targeting. Brain Res Bull. 2018;143:155\u201370.","journal-title":"Brain Res Bull"},{"key":"2974_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","volume":"195","author":"TP Crowe","year":"2018","unstructured":"Crowe TP, Greenlee MHW, Kanthasamy AG, Hsu WH. Mechanism of intranasal drug delivery directly to the brain. Life Sci. 2018;195:44\u201352.","journal-title":"Life Sci"},{"key":"2974_CR40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s40005-022-00589-5","volume":"35","author":"S-H Jeong","year":"2023","unstructured":"Jeong S-H, Jang J-H, Lee YB. Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors. J Pharm Investig. 2023;35:119\u201352.","journal-title":"J Pharm Investig"},{"key":"2974_CR41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jconrel.2018.12.049","volume":"295","author":"C Costa","year":"2019","unstructured":"Costa C, Moreira JN, Amaral MH, Sousa Lobo JM, Silva AC. Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis. J Controlled Release. 2019;295:187\u2013200.","journal-title":"J Controlled Release"},{"key":"2974_CR42","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jconrel.2016.07.001","volume":"237","author":"M Kapoor","year":"2016","unstructured":"Kapoor M, Cloyd JC, Siegel RA. A review of intranasal formulations for the treatment of seizure emergencies. J Controlled Release. 2016;237:147\u201359.","journal-title":"J Controlled Release"},{"key":"2974_CR43","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/17425247.2021.1823965","volume":"18","author":"M Shringarpure","year":"2021","unstructured":"Shringarpure M, Gharat S, Momin M, Omri A. Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery. Expert Opin Drug Deliv. 2021;18:169\u201385.","journal-title":"Expert Opin Drug Deliv"},{"key":"2974_CR44","doi-asserted-by":"publisher","unstructured":"Lee D, Minko T. Nanotherapeutics for nose-to-brain drug delivery: An approach to bypass the blood brain barrier. Pharmaceutics. 2021;13. https:\/\/doi.org\/10.3390\/pharmaceutics13122049.","DOI":"10.3390\/pharmaceutics13122049"},{"key":"2974_CR45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-3-031-23112-4_4","volume-title":"Nasal Drug Delivery","author":"JB Da Silva","year":"2023","unstructured":"Da Silva JB, Botan MVG, Bruschi ML. Factors Affecting the Design of Nasal drug delivery System. In: Pathak YV, Yadav HKS, editors. Nasal drug delivery. Springer International Publishing; 2023. pp. 43\u201358."},{"key":"2974_CR46","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ijpharm.2009.06.019","volume":"379","author":"A Mistry","year":"2009","unstructured":"Mistry A, Stolnik S, Illum L. Nanoparticles for direct nose-to-brain delivery of drugs. Int J Pharm. 2009;379:146\u201357.","journal-title":"Int J Pharm"},{"key":"2974_CR47","first-page":"2088","volume":"46","author":"K Selvaraj","year":"2018","unstructured":"Selvaraj K, Gowthamarajan K, Karri VVSR. Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting. Artif Cells Nanomed Biotechnol. 2018;46:2088\u201395.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"2974_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2174\/157488507779422374","volume":"2","author":"KR Jadhav","year":"2007","unstructured":"Jadhav KR, Gambhire MN, Shaikh IM, Kadam VJ, Pisal SS. Nasal drug delivery system-factors affecting and applications. Curr Drug ther. 2007;2:27\u201338.","journal-title":"Curr Drug ther"},{"key":"2974_CR49","first-page":"1167","volume":"44","author":"P Kaur","year":"2016","unstructured":"Kaur P, Garg T, Rath G, Goyal AK. In situ nasal gel drug delivery: a novel approach for brain targeting through the mucosal membrane. Artif Cells Nanomed Biotechnol. 2016;44:1167\u201376.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"2974_CR50","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v23.i4.20","volume":"23","author":"TK Vyas","year":"2006","unstructured":"Vyas TK, Tiwari SB, Amiji MM. Formulation and physiological factors influencing CNS delivery upon Intranasal Administration. Crit Reviews TM Therapeutic Drug Carrier Syst [Internet]. 2006;23:319\u201347.","journal-title":"Crit Reviews TM Therapeutic Drug Carrier Syst [Internet]"},{"key":"2974_CR51","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s13346-012-0108-9","volume":"3","author":"PG Djupesland","year":"2013","unstructured":"Djupesland PG. Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review. Drug Deliv Transl Res. 2013;3:42\u201362.","journal-title":"Drug Deliv Transl Res"},{"key":"2974_CR52","doi-asserted-by":"publisher","unstructured":"Alabsi W, Eedara BB, Encinas-Basurto D, Polt R, Mansour HM. Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols. Pharmaceutics. 2022;14. https:\/\/doi.org\/10.3390\/pharmaceutics14091870.","DOI":"10.3390\/pharmaceutics14091870"},{"key":"2974_CR53","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13346-021-00940-7","volume":"11","author":"LC Fonseca","year":"2021","unstructured":"Fonseca LC, Lopes JA, Vieira J, Viegas C, Oliveira CS, Hartmann RP, et al. Intranasal drug delivery for treatment of Alzheimer\u2019s disease. Drug Deliv Transl Res. 2021;11:411\u201325.","journal-title":"Drug Deliv Transl Res"},{"key":"2974_CR54","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-3-031-23112-4","volume-title":"Nasal Drug Delivery","author":"VY Pathak","year":"2023","unstructured":"Pathak VY, Yadav HKS. Novel Mucoadhesive Polymers for Nasal Drug Delivery. In: Pathak VY, Yadav HKS, editors. Nasal Drug Delivery. Springer International Publishing; 2023. p. 189\u2013234."},{"key":"2974_CR55","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4155\/tde-2019-0086","volume":"11","author":"R Scherlie\u00df","year":"2020","unstructured":"Scherlie\u00df R. Nasal formulations for drug administration and characterization of nasal preparations in drug delivery. Ther Deliv. 2020;11:183\u201391.","journal-title":"Ther Deliv"},{"key":"2974_CR56","doi-asserted-by":"publisher","unstructured":"Tai J, Han M, Lee D, Park IH, Lee SH, Kim TH. Different Methods and Formulations of Drugs and Vaccines for Nasal Administration. Pharmaceutics. 2022;14. https:\/\/doi.org\/10.3390\/pharmaceutics14051073.","DOI":"10.3390\/pharmaceutics14051073"},{"key":"2974_CR57","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.2174\/1381612826666201112143230","volume":"27","author":"J Chen","year":"2020","unstructured":"Chen J, Martin AR, Finlay WH. Recent in Vitro and in Silico Advances in the understanding of Intranasal Drug Delivery. Curr Pharm Des. 2020;27:1482\u201397.","journal-title":"Curr Pharm Des"},{"key":"2974_CR58","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/lio2.1190","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wu D. Bi-directional nasal drug delivery systems: a scoping review of nasal particle deposition patterns and clinical application. Laryngoscope Investig Otolaryngol. 2023;8:1484\u201399.","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"2974_CR59","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1517\/17425247.2011.588204","volume":"8","author":"F Malerba","year":"2011","unstructured":"Malerba F, Paoletti F, Capsoni S, Cattaneo A. Intranasal delivery of therapeutic proteins for neurological diseases. Expert Opin Drug Deliv. 2011;8:1277\u201396.","journal-title":"Expert Opin Drug Deliv"},{"key":"2974_CR60","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1080\/1061186X.2023.2271680","volume":"31","author":"T Salehi","year":"2023","unstructured":"Salehi T, Raeisi Estabragh MA, Salarpour S, Ohadi M, Dehghannoudeh G. Absorption enhancer approach for protein delivery by various routes of administration: a rapid review. J Drug Target. 2023;31:950\u201361.","journal-title":"J Drug Target"},{"key":"2974_CR61","doi-asserted-by":"publisher","unstructured":"Viswanadhan Vasantha P, Sherafudeen SP, Rahamathulla M, Mathew ST, Murali S, Alshehri S, et al. Combination of Cellulose Derivatives and Chitosan-Based Polymers to Investigate the Effect of Permeation Enhancers Added to In Situ Nasal Gels for the Controlled Release of Loratadine and Chlorpheniramine. Polym (Basel). 2023;15. https:\/\/doi.org\/10.3390\/polym15051206.","DOI":"10.3390\/polym15051206"},{"key":"2974_CR62","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.2147\/IJN.S403707","volume":"18","author":"FM Elsharkawy","year":"2023","unstructured":"Elsharkawy FM, Amin MM, Shamsel-Din HA, Ibrahim W, Ibrahim AB, Sayed S. Self-assembling lecithin-based mixed polymeric micelles for nose to Brain Delivery of Clozapine: In-vivo Assessment of Drug Efficacy via Radiobiological evaluation. Int J Nanomed. 2023;18:1577\u201395.","journal-title":"Int J Nanomed"},{"key":"2974_CR63","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1517\/17425247.5.10.1159","volume":"5","author":"H Wu","year":"2008","unstructured":"Wu H, Hu K, Jiang X. From nose to brain: understanding transport capacity and transport rate of drugs. Expert Opin Drug Deliv. 2008;5:1159\u201368.","journal-title":"Expert Opin Drug Deliv"},{"key":"2974_CR64","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1023\/A:1015949013644","volume":"6","author":"MA Hussain","year":"1989","unstructured":"Hussain MA, Shenvi AB, Rowe SM, Shefter E. The Use of \u03b1-Aminoboronic Acid Derivatives to Stabilize Peptide Drugs During Their Intranasal Absorption. Pharm Res. 1989;6:186\u20139.","journal-title":"Pharm Res"},{"key":"2974_CR65","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","volume":"268","author":"AR Khan","year":"2017","unstructured":"Khan AR, Liu M, Khan MW, Zhai G. Progress in brain targeting drug delivery system by nasal route. J Controlled Release. 2017;268:364\u201389.","journal-title":"J Controlled Release"},{"key":"2974_CR66","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0168-3659(90)90099-F","volume":"12","author":"S-HS Leung","year":"1990","unstructured":"Leung S-HS, Robinson JR. Polymer structure features contributing to mucoadhesion. II. J Controlled Release. 1990;12:187\u201394.","journal-title":"J Controlled Release"},{"key":"2974_CR67","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.addr.2005.07.001","volume":"57","author":"JD Smart","year":"2005","unstructured":"Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev. 2005;57:1556\u201368.","journal-title":"Adv Drug Deliv Rev"},{"key":"2974_CR68","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1517\/17425240903473134","volume":"7","author":"M Davidovich-Pinhas","year":"2010","unstructured":"Davidovich-Pinhas M, Bianco-Peled H, Mucoadhesion. A review of characterization techniques. Expert Opin Drug Deliv. 2010;7:259\u201371.","journal-title":"Expert Opin Drug Deliv"},{"key":"2974_CR69","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jpba.2018.04.041","volume":"156","author":"S Rossi","year":"2018","unstructured":"Rossi S, Vigani B, Bonferoni MC, Sandri G, Caramella C, Ferrari F. Rheological analysis and mucoadhesion: a 30 year-old and still active combination. J Pharm Biomed Anal. 2018;156:232\u20138.","journal-title":"J Pharm Biomed Anal"},{"key":"2974_CR70","doi-asserted-by":"publisher","unstructured":"Gremi\u00e3o MPD, Carvalho FC, Bruschi ML, Evangelista RC, Palmira M, Gremi\u00e3o D. Mucoadhesive drug delivery systems. Brazilian J Pharm Sci. 2010;46. https:\/\/doi.org\/10.1590\/S1984-82502010000100002.","DOI":"10.1590\/S1984-82502010000100002"},{"key":"2974_CR71","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4103\/0110-5558.76436","volume":"1","author":"BM Boddupalli","year":"2010","unstructured":"Boddupalli BM, Mohammed ZNK, Nath AR, Banji D. Mucoadhesive drug delivery system: an overview. J Adv Pharm Technol Res. 2010;1:381\u20137.","journal-title":"J Adv Pharm Technol Res"},{"key":"2974_CR72","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/mabi.201000388","volume":"11","author":"VV Khutoryanskiy","year":"2011","unstructured":"Khutoryanskiy VV. Advances in Mucoadhesion and Mucoadhesive polymers. Macromol Biosci. 2011;11:748\u201364.","journal-title":"Macromol Biosci"},{"key":"2974_CR73","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jsps.2015.02.025","volume":"24","author":"B Karolewicz","year":"2016","unstructured":"Karolewicz B. A review of polymers as multifunctional excipients in drug dosage form technology. Saudi Pharm J. 2016;24:525\u201336.","journal-title":"Saudi Pharm J"},{"key":"2974_CR74","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.addr.2005.07.006","volume":"57","author":"V Grabovac","year":"2005","unstructured":"Grabovac V, Guggi D, Bernkop-Schn\u00fcrch A. Comparison of the mucoadhesive properties of various polymers. Adv Drug Deliv Rev. 2005;57:1713\u201323.","journal-title":"Adv Drug Deliv Rev"},{"key":"2974_CR75","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1590\/S0100-40422006000400031","volume":"29","author":"SMM Franchetti","year":"2006","unstructured":"Franchetti SMM, Marconato JC. Pol\u00edmeros biodegrad\u00e1veis - Uma solu\u00e7\u00e3o parcial para diminuir a quantidade dos res\u00edduos pl\u00e1sticos. Quim Nova. 2006;29:811\u20136.","journal-title":"Quim Nova"},{"key":"2974_CR76","doi-asserted-by":"publisher","unstructured":"Oprea M, Voicu SI. Recent advances in composites based on cellulose derivatives for biomedical applications. Carbohydr Polym. 2020;247. https:\/\/doi.org\/10.1016\/j.carbpol.2020.116683.","DOI":"10.1016\/j.carbpol.2020.116683"},{"key":"2974_CR77","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s13346-020-00800-w","volume":"11","author":"CT Uppuluri","year":"2021","unstructured":"Uppuluri CT, Ravi PR, Dalvi AV, Shaikh SS, Kale SR. Piribedil loaded thermo-responsive nasal in situ gelling system for enhanced delivery to the brain: formulation optimization, physical characterization, and in vitro and in vivo evaluation. Drug Deliv Transl Res. 2021;11:909\u201326.","journal-title":"Drug Deliv Transl Res"},{"key":"2974_CR78","doi-asserted-by":"publisher","unstructured":"Corazza E, di Cagno MP, Bauer-Brandl A, Abruzzo A, Cerchiara T, Bigucci F, et al. Drug delivery to the brain: In situ gelling formulation enhances carbamazepine diffusion through nasal mucosa models with mucin. Eur J Pharm Sci. 2022;179. https:\/\/doi.org\/10.1016\/j.ejps.2022.106294.","DOI":"10.1016\/j.ejps.2022.106294"},{"key":"2974_CR79","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ijbiomac.2022.06.031","volume":"213","author":"S Ourani-Pourdashti","year":"2022","unstructured":"Ourani-Pourdashti S, Mirzaei E, Heidari R, Ashrafi H, Azadi A. Preparation and evaluation of niosomal chitosan-based in situ gel formulation for direct nose-to-brain methotrexate delivery. Int J Biol Macromol. 2022;213:1115\u201326.","journal-title":"Int J Biol Macromol"},{"key":"2974_CR80","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s12668-020-00767-5","volume":"10","author":"S Shelke","year":"2020","unstructured":"Shelke S, Pathan I, Shinde G, Agrawal G, Damale M, Chouthe R, et al. Poloxamer-based in situ nasal gel of Naratriptan Hydrochloride Deformable vesicles for Brain Targeting. Bionanoscience. 2020;10:633\u201348.","journal-title":"Bionanoscience"},{"key":"2974_CR81","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eurpolymj.2015.01.016","volume":"65","author":"M Hrub\u00fd","year":"2015","unstructured":"Hrub\u00fd M, Filippov SK, \u0160t\u011bp\u00e1nek P. Smart polymers in drug delivery systems on crossroads: which way deserves following? Eur Polym J. 2015;65:82\u201397.","journal-title":"Eur Polym J"},{"key":"2974_CR82","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejpb.2008.04.025","volume":"70","author":"L Mayol","year":"2008","unstructured":"Mayol L, Quaglia F, Borzacchiello A, Ambrosio L, Rotonda MIL. A novel poloxamers\/hyaluronic acid in situ forming hydrogel for drug delivery: Rheological, mucoadhesive and in vitro release properties. Eur J Pharm Biopharm. 2008;70:199\u2013206.","journal-title":"Eur J Pharm Biopharm"},{"key":"2974_CR83","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/17425247.2020.1731469","volume":"17","author":"H Abdeltawab","year":"2020","unstructured":"Abdeltawab H, Svirskis D, Sharma M. Formulation strategies to modulate drug release from poloxamer based in situ gelling systems. Expert Opin Drug Deliv. 2020;17:495\u2013509.","journal-title":"Expert Opin Drug Deliv"},{"key":"2974_CR84","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1590\/0104-1428.1831","volume":"25","author":"LMU Dutra","year":"2015","unstructured":"Dutra LMU, Ribeiro MENP, Cavalcante IM, De Brito DHA, De Moraes Semi\u00e3o L, Da Silva RF, et al. Binary mixture micellar systems of F127 and P123 for griseofulvin solubilisation. Pol\u00edmeros. 2015;25:433\u20139.","journal-title":"Pol\u00edmeros"},{"key":"2974_CR85","doi-asserted-by":"publisher","unstructured":"Hsieh HY, Lin WY, Lee AL, Li YC, Chen YJ, Chen KC, et al. Hyaluronic acid on the urokinase sustained release with a hydrogel system composed of poloxamer 407: HA\/P407 hydrogel system for drug delivery. PLoS ONE. 2020;15. https:\/\/doi.org\/10.1371\/journal.pone.0227784.","DOI":"10.1371\/journal.pone.0227784"},{"key":"2974_CR86","doi-asserted-by":"publisher","unstructured":"Giuliano E, Paolino D, Fresta M, Cosco D. Mucosal applications of poloxamer 407-based hydrogels: An overview. Pharmaceutics. 2018;10. https:\/\/doi.org\/10.3390\/pharmaceutics10030159.","DOI":"10.3390\/pharmaceutics10030159"},{"key":"2974_CR87","first-page":"2391","volume":"10","author":"ACM dos Santos","year":"2015","unstructured":"dos Santos ACM, Akkari ACS, Ferreira IRS, Maruyama CR, Pascoli M, Guilherme VA, et al. Poloxamer-based binary hydrogels for delivering tramadol hydrochloride: Sol-gel transition studies, dissolution-release kinetics, in vitro toxicity, and pharmacological evaluation. Int J Nanomed. 2015;10:2391\u2013401.","journal-title":"Int J Nanomed"},{"key":"2974_CR88","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1007\/s11095-006-9104-4","volume":"23","author":"G Dumortier","year":"2006","unstructured":"Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res. 2006;23:2709\u201328.","journal-title":"Pharm Res"},{"key":"2974_CR89","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jconrel.2023.01.070","volume":"355","author":"LR Michels","year":"2023","unstructured":"Michels LR, Fachel FNS, Schuh RS, Azambuja JH, de Souza PO, Gelsleichter NE, et al. Nasal administration of a temozolomide-loaded thermoresponsive nanoemulsion reduces tumor growth in a preclinical glioblastoma model. J Controlled Release. 2023;355:343\u201357.","journal-title":"J Controlled Release"},{"key":"2974_CR90","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1039\/C9TB02052G","volume":"8","author":"F Doberenz","year":"2020","unstructured":"Doberenz F, Zeng K, Willems C, Zhang K, Groth T. Thermoresponsive polymers and their biomedical application in tissue engineering - A review. J Mater Chem B. 2020;8:607\u201328.","journal-title":"J Mater Chem B"},{"key":"2974_CR91","first-page":"01","volume":"2","author":"H Almeida","year":"2012","unstructured":"Almeida H, Amaral MH, Lob\u00e3o P. Temperature and pH stimuli-responsive polymers and their applications in controlled and selfregulated drug delivery. J Appl Pharm Sci. 2012;2:01\u201310.","journal-title":"J Appl Pharm Sci"},{"key":"2974_CR92","doi-asserted-by":"publisher","unstructured":"Afloarea OT, Cheaburu Yilmaz CN, Verestiuc L, Bibire N. Development of Vaginal Carriers Based on Chitosan-Grafted-PNIPAAm for Progesterone Administration. Gels. 2022;8. https:\/\/doi.org\/10.3390\/gels8090596.","DOI":"10.3390\/gels8090596"},{"key":"2974_CR93","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s13346-022-01197-4","volume":"13","author":"SK Hari","year":"2023","unstructured":"Hari SK, Gauba A, Shrivastava N, Tripathi RM, Jain SK, Pandey AK. Polymeric micelles and cancer therapy: an ingenious multimodal tumor-targeted drug delivery system. Drug Deliv Transl Res. 2023;13:135\u201363.","journal-title":"Drug Deliv Transl Res"},{"key":"2974_CR94","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jcis.2021.12.016","volume":"611","author":"H Mateos","year":"2022","unstructured":"Mateos H, Gentile L, Murgia S, Colafemmina G, Collu M, Smets J, et al. Understanding the self-assembly of the polymeric drug solubilizer Soluplus\u00ae. J Colloid Interface Sci. 2022;611:224\u201334.","journal-title":"J Colloid Interface Sci"},{"key":"2974_CR95","doi-asserted-by":"publisher","unstructured":"Salah I, Shamat MA, Cook MT. Soluplus solutions as thermothickening materials for topical drug delivery. J Appl Polym Sci. 2019;136. https:\/\/doi.org\/10.1002\/app.46915.","DOI":"10.1002\/app.46915"},{"key":"2974_CR96","doi-asserted-by":"publisher","first-page":"122594","DOI":"10.1016\/j.ijpharm.2023.122594","volume":"632","author":"B Sipos","year":"2023","unstructured":"Sipos B, Bella Z, Gr\u00f3f I, Veszelka S, Deli MA, Sz\u0171cs KF, et al. Soluplus\u00ae promotes efficient transport of meloxicam to the central nervous system via nasal administration. Int J Pharm. 2023;632:122594.","journal-title":"Int J Pharm"},{"key":"2974_CR97","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.colsurfa.2014.01.007","volume":"458","author":"S Lefnaoui","year":"2014","unstructured":"Lefnaoui S, Moulai-Mostefa N. Investigation and optimization of formulation factors of a hydrogel network based on kappa carrageenan-pregelatinized starch blend using an experimental design. Colloids Surf Physicochem Eng Asp. 2014;458:117\u201325.","journal-title":"Colloids Surf Physicochem Eng Asp"},{"key":"2974_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2007.09.012","volume":"125","author":"F Siepmann","year":"2008","unstructured":"Siepmann F, Siepmann J, Walther M, MacRae RJ, Bodmeier R. Polymer blends for controlled release coatings. J Controlled Release. 2008;125:1\u201315.","journal-title":"J Controlled Release"},{"key":"2974_CR99","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.polymer.2015.05.008","volume":"68","author":"M Muthuvinayagam","year":"2015","unstructured":"Muthuvinayagam M, Gopinathan C. Characterization of proton conducting polymer blend electrolytes based on PVdF-PVA. Polym (Guildf). 2015;68:122\u201330.","journal-title":"Polym (Guildf)"},{"key":"2974_CR100","doi-asserted-by":"publisher","unstructured":"Le TMD, Yoon AR, Thambi T, Yun CO. Polymeric Systems for Cancer Immunotherapy: A Review. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.826876.","DOI":"10.3389\/fimmu.2022.826876"},{"key":"2974_CR101","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1021\/bm060090l","volume":"7","author":"AV Dubolazov","year":"2006","unstructured":"Dubolazov AV, Nurkeeva ZS, Mun GA, Khutoryanskiy VV. Design of mucoadhesive polymeric films based on blends of poly(acrylic acid) and (hydroxypropyl)cellulose. Biomacromolecules. 2006;7:1637\u201343.","journal-title":"Biomacromolecules"},{"key":"2974_CR102","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ijpharm.2005.07.024","volume":"304","author":"F Kang","year":"2005","unstructured":"Kang F, Singh J. In vitro release of insulin and biocompatibility of in situ forming gel systems. Int J Pharm. 2005;304:83\u201390.","journal-title":"Int J Pharm"},{"key":"2974_CR103","doi-asserted-by":"publisher","first-page":"E88","DOI":"10.1208\/pt0803062","volume":"8","author":"RA Graves","year":"2007","unstructured":"Graves RA, Freeman T, Mandal TK. \u00a0Vitro Dissolution Method for Evaluation of Buprenorphine In Situ Gel Formulation: A Technical Note. AAPS PharmSciTech. 2007;8:E88\u201399.","journal-title":"AAPS PharmSciTech"},{"key":"2974_CR104","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3109\/1061186X.2012.719230","volume":"20","author":"S Wang","year":"2012","unstructured":"Wang S, Chen P, Zhang L, Yang C, Zhai G. Formulation and evaluation of microemulsion-based in situ ion-sensitive gelling systems for intranasal administration of curcumin. J Drug Target. 2012;20:831\u201340.","journal-title":"J Drug Target"},{"key":"2974_CR105","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ijpharm.2019.01.044","volume":"559","author":"OD Akilo","year":"2019","unstructured":"Akilo OD, Kumar P, Choonara YE, du Toit LC, Pradeep P, Modi G, et al. In situ thermo-co-electroresponsive mucogel for controlled release of bioactive agent. Int J Pharm. 2019;559:255\u201370.","journal-title":"Int J Pharm"},{"key":"2974_CR106","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1007\/s12668-023-01290-z","volume":"14","author":"R Shikalgar","year":"2024","unstructured":"Shikalgar R, Deshmukh V, Rathod S, Bangale GS, Pore YV, Pawar DP. Fabrication of PF-127 based Niosomal in situ gel for Intranasal Delivery of Lurasidone Hydrochloride and optimization by using 32 Factorial Design. Bionanoscience. 2024;14:1318\u201339.","journal-title":"Bionanoscience"},{"key":"2974_CR107","doi-asserted-by":"publisher","unstructured":"Emad NA, Ahmed B, Alhalmi A, Alzobaidi N, Al-Kubati SS. Recent progress in nanocarriers for direct nose to brain drug delivery. J Drug Deliv Sci Technol. 2021;64. https:\/\/doi.org\/10.1016\/j.jddst.2021.102642.","DOI":"10.1016\/j.jddst.2021.102642"},{"key":"2974_CR108","doi-asserted-by":"publisher","unstructured":"Jufri M, Yuwanda A, Surini S, Harahap Y. Study of valproic acid liposomes for delivery into the brain through an intranasal route. Heliyon. 2022;8. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09030.","DOI":"10.1016\/j.heliyon.2022.e09030"},{"key":"2974_CR109","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/DDDT.S113171","volume":"10","author":"AK Al Asmari","year":"2016","unstructured":"Al Asmari AK, Ullah Z, Tariq M, Fatani A. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil. Drug Des Devel Ther. 2016;10:205\u201315.","journal-title":"Drug Des Devel Ther"},{"key":"2974_CR110","doi-asserted-by":"publisher","unstructured":"Khot KB, Gopan DSS, Deshpande G, Shastry NS, Bandiwadekar P. Enhancing selegiline hydrochloride efficacy: Box Behnken-optimized liposomal delivery via intranasal route for Parkinson\u2019s disease intervention. J Liposome Res. 2024. https:\/\/doi.org\/10.1080\/08982104.2024.2336549.","DOI":"10.1080\/08982104.2024.2336549"},{"key":"2974_CR111","doi-asserted-by":"publisher","unstructured":"Sita VG, Jadhav D, Vavia P. Niosomes for nose-to-brain delivery of bromocriptine: Formulation development, efficacy evaluation and toxicity profiling. J Drug Deliv Sci Technol. 2020;58. https:\/\/doi.org\/10.1080\/08982104.2024.2336549.","DOI":"10.1080\/08982104.2024.2336549"},{"key":"2974_CR112","doi-asserted-by":"publisher","unstructured":"Al Jayoush AR, Hassan HAFM, Asiri H, Jafar M, Saeed R, Harati R, et al. Niosomes for nose-to-brain delivery: A non-invasive versatile carrier system for drug delivery in neurodegenerative diseases. J Drug Deliv Sci Technol. 2023;89. https:\/\/doi.org\/10.1016\/j.jddst.2023.105007.","DOI":"10.1016\/j.jddst.2023.105007"},{"key":"2974_CR113","doi-asserted-by":"publisher","unstructured":"Dighe S, Jog S, Momin M, Sawarkar S, Omri A. Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer\u2019s Disease Management. Pharmaceutics. 2024;16. https:\/\/doi.org\/10.3390\/pharmaceutics16010058.","DOI":"10.3390\/pharmaceutics16010058"},{"key":"2974_CR114","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.foodchem.2013.09.088","volume":"147","author":"M Sessa","year":"2014","unstructured":"Sessa M, Balestrieri ML, Ferrari G, Servillo L, Castaldo D, D\u2019Onofrio N, et al. Bioavailability of encapsulated resveratrol into nanoemulsion-based delivery systems. Food Chem. 2014;147:42\u201350.","journal-title":"Food Chem"},{"key":"2974_CR115","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/02652048.2020.1756971","volume":"37","author":"A Kaur","year":"2020","unstructured":"Kaur A, Nigam K, Srivastava S, Tyagi A, Dang S. Memantine nanoemulsion: a new approach to treat Alzheimer\u2019s disease. J Microencapsul. 2020;37:355\u201365.","journal-title":"J Microencapsul"},{"key":"2974_CR116","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1080\/10837450.2021.1950186","volume":"26","author":"R Lombardo","year":"2021","unstructured":"Lombardo R, Musumeci T, Carbone C, Pignatello R. Nanotechnologies for intranasal drug delivery: an update of literature. Pharm Dev Technol. 2021;26:824\u201345.","journal-title":"Pharm Dev Technol"},{"key":"2974_CR117","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.apsb.2014.02.002","volume":"4","author":"R Pathak","year":"2014","unstructured":"Pathak R, Prasad Dash R, Misra M, Nivsarkar M. Role of mucoadhesive polymers in enhancing delivery of nimodipine microemulsion to brain via intranasal route. Acta Pharm Sin B. 2014;4:151\u201360.","journal-title":"Acta Pharm Sin B"},{"key":"2974_CR118","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jconrel.2012.01.024","volume":"161","author":"L Illum","year":"2012","unstructured":"Illum L. Nasal drug delivery \u2013 recent developments and future prospects. J Control Rel. 2012;161:254\u201363.","journal-title":"J Control Rel"},{"key":"2974_CR119","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/978-3-031-23112-4_18","volume-title":"Nasal Drug Delivery","author":"A Abdelkawi","year":"2023","unstructured":"Abdelkawi A, Martinez JPR, Pathak YV. Is there a global market and opportunities for nasal drug delivery? Recent trends in global nasal delivery market. In: Pathak YV, Yadav HKS, editors. Nasal Drug Delivery. Springer International Publishing; 2023. p. 381\u201392."}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-02974-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-024-02974-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-02974-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T04:11:54Z","timestamp":1733890314000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-024-02974-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":119,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2974"],"URL":"https:\/\/doi.org\/10.1208\/s12249-024-02974-9","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"assertion":[{"value":"17 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"258"}}